[1]
|
F. Giangaspero, C. G. Eberhart, H. Haapasalo, T. Pietsch, O. D. Wiestler and D. W. Ellison, “WHO Classification of Tumors of Central Nervous System,” In: D. N. Louis, H. Ohgaki, O. D. Wiestler and W. K. Cavenee, Eds., IARC Press, Lyon, 2007, pp. 132-140.
|
[2]
|
C. Ang, D. Hauerstock, M. C. Guiot, et al., “Characteristics and Outcome of Medulloblastoma in Adults,” Blood Cancer, Vol. 51, 2008, pp. 603-607.
|
[3]
|
L. Riffaud, S. Saikali, E. Leray, et al., “Survival and Prognostic Factors in a Series of Adults with Medulloblastomas,” Journal of Neurosurgery, Vol. 111, 2009, pp. 478-487.
|
[4]
|
A. Gajjar, M. Chintagumpala, D. Ashley, et al., “Risk- adapted Craniospinal Radiotherapy Followed by High- Dose Chemotherapy and Stem-Cell Rescue in Children with Newly Diagnosed Medulloblastoma (St Jude Medulloblastoma-96): Long-Term Results from a Prospective, Multicentre Trial,” Lancet Oncology, Vol. 7, 2006, pp. 813-820.
|
[5]
|
A. Peyrl, K. Krapfenbauer, I. Slavc, et al., “Protein Profiles of Medulloblastoma Cell Lines DAOY and D283: Identification of Tumor-Related Proteins and Principles,” Proteomics, Vol. 3, 2003, pp. 1781-1800.
|
[6]
|
G. Barbero, F. Carta, G. Giribaldi, et al., “Protein/RNA Coextraction and Small Twodimensional Polyacrylamide Gel Electrophoresis for Proteomic/Gene Expression Analysis of Renal Cancer Biopsies,” Analytical Biochemistry, Vol. 349, 2006, pp. 62-71.
|
[7]
|
F. Carta, P. P. Demuro, C. Zanini, et al., “Analysis of Candidate Genes through a Proteomicsbased Approach in Primary Cell Lines from Malignant Melanomas and their Metastases,” Melanoma Research, Vol. 15, 2005, pp. 235-244.
|
[8]
|
M. Mojsin, M. Stevanovic, “PBX1 and MEIS 1 Up-regulate SOX3gene Expression by Direct Iteraction with a Consensus Binding Site within the Basal Promoter Region,” Biochemical Journal, Vol. 425, 2009, pp. 107- 116.
|
[9]
|
M. F. Kuo, H. S. Wang, Q. T. Kuo, et al., “High Expression of Stathmin Protein Predicts a Fulminant Course in Medulloblastoma,” Journal of Neurosurgery: Pediatrics, Vol. 4, 2009, pp. 74-80.
|
[10]
|
C. Zanini, G. Giribaldi, G. Mandili, et al., “Inhibition of Heat Shock Proteins (HSP) Expression by Quercetin and Differential Doxorubicin Sensitization in Neuroblastoma and Ewing’s Sarcoma Cell Lines,” Journal of Neurochemistry, Vol. 103, 2007, pp. 1344-1354.
|
[11]
|
Y. J. Qi, Q. Y. He, Y. F. Ma, et al., “Proteomic Identification of Malignant Transformation-Related Proteins in Esophageal Squamous Cell Carcinoma,” Journal of Cellular Biochemistry, Vol. 104, 2008, pp. 625-635.
|
[12]
|
U. Selek, F. Zorlu, P. Hurmuz, et al., “Craniospinal Radiotherapy in Adult Medulloblastoma,” Strahlentherapie und Onkologie, Vol. 183, 2007, pp. 236-240.
|
[13]
|
F. Spreafico, M. Massimino, L. Gandola, et al., “Survival of Adults Treated for Medulloblastoma Using Paediatric protocols,” European Journal of Cancer, Vol. 41, 2005, pp. 1304-1310.
|
[14]
|
B. B. Ma, R. G. Bristow, J. Kim, L. L. Siu, “Combined modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents,” Journal of Clinical Oncology, Vol. 21, 2003, pp. 2760-2776.
|
[15]
|
A. S. Allal, T. Kahne, A. K. Reverdin, et al., “Radioresistance-Related Proteins in Rectal Cancer,” Proteomics, Vol. 4, 2004, pp. 2261-2269.
|
[16]
|
L. Smith, O. Qutob, M. B. Watson, et al., “Proteomic Identification of Putative Biomarkers of Radiotherapy Resistence: A Possible Role of the 26S Proteasome?” Neoplasia, Vol. 11, 2009, pp. 1194-1207.
|
[17]
|
D. Hambardzumyan, O. J. Becher, M. K. Rosenblum, et al., “PI3K Pathway Regulates Survival of Cancer Stem Cells Residing in the Perivascular Niche Following Radiation in Medulloblastoma in Vivo,” Genes, Vol. 22, 2008, pp. 436-448.
|
[18]
|
C. S. McManamy, J. Pears, C. L. Weston, et al., “Nodule Formation and Desmoplasia in Medulloblastomas- Defining the Nodular/Desmoplastic Variant and its Biological Behavior,” Brain Pathology, Vol. 17, 2007, pp. 151-164.
|
[19]
|
F. J. Rodriguez, C. Eberhart, B. P. O’Neill, et al., “Histopathologic Grading of Adult Medulloblastomas,” Cancer, Vol. 9, 2007, pp. 2557-2565.
|
[20]
|
W. N. Hait, “Targeted Cancer Therapeutics,” Cancer Research, Vol. 69, 2009, pp. 1263-1267.
|